Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijcard.2019.10.050 | DOI Listing |
PLoS One
December 2024
Heart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Background: Heart failure (HF) is still associated with quite considerable mortality rates and usage of simple tools for prognosis is pivotal. We aimed to evaluate the effect of shock index (SI) and its derivatives (age SI (ASI), modified SI (MSI), and age MSI (AMSI)) on acute HF (AHF) clinical outcomes.
Methods: PubMed/Medline, Scopus and Web of science databases were screened with no time and language limitations till February 2024.
J Am Soc Echocardiogr
December 2024
MIRACL.ai laboratory, Multimodality Imaging for Research and Analysis Core Laboratory and Artificial Intelligence, University Hospital of Lariboisiere (AP-HP), 75010, Paris, France; Université Paris Cité, Service de Cardiologie, Hôpital Lariboisière - Assistance Publique des Hôpitaux de Paris (APHP), Inserm UMRS 942, 75010, Paris, France. Electronic address:
Am J Cardiovasc Drugs
December 2024
Division of Cardiovascular Medicine, Krannert Cardiovascular Research Center, Indiana University School of Medicine, 1801 N Senate Ave Suite 2000, Indianapolis, IN, 46202, USA.
Introduction: Inadequate decongestion remains an unmet need in the management of patients with heart failure. The concept of door-to-diuretic (D2D) time to improve outcomes has been proposed for patients with heart failure (HF), but the trial results have been mixed.
Methods: We utilized Preferred Reporting Instrument for Systematic Reviews and Meta-Analysis Extension for Scoping Reviews (PRISMA-ScR) for scoping reviews with an extensive a priori search strategy for databases: PubMed and Scopus between January 2015 and November 2023.
J Cardiovasc Electrophysiol
January 2025
Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czechia.
Introduction: Atrial fibrillation (AF) can cause or aggravate heart failure (HF). Catheter ablation (CA) is an effective treatment for AF. This study focused on the feasibility and outcomes of emergent AF ablation performed during hospitalization for acute HF.
View Article and Find Full Text PDFTrials
November 2024
Beijing Anzhen Hospital, the Capital Medical University, Beijing, China.
Background: Influenza vaccination confers broad benefits in the elderly and certain high-risk populations, but its effectiveness in patients with acute heart failure (HF) is uncertain. Rates of influenza vaccination are low in China due to poor awareness, cultural misunderstandings, and cost.
Aims: To determine the effectiveness of influenza vaccination in patients with acute HF admitted to hospitals in China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!